Atossa Therapeutics

Atossa Therapeutics to Participate in Tribe Public's Webinar Event "Redefining Breast Cancer Prevention and Treatment" - Atossa Therapeutics Virtual webinar scheduled for Thursday, May 4 at 8:00 am pacific / 11:00 am easternMeet with Atossa's Founder and CEO, Steven Quay, M.D., Ph.D.Event is open to the public - registration available at ATOS5423.TribePublic.com SEATTLE, April 27, 2023 (GLOBE...

Atossa Therapeutics, Inc. Announces Appointment of Pharma Industry Veteran Richard Graydon, M.D., Ph.D. - Atossa Therapeutics Oversaw FDA approval of CAR-T/CAR-NK cell therapy, ADCs, and small molecule/targeted therapies for hematology-oncology diseasesSEATTLE, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to develop innovative medicines in ar...